Inflammation, indicated by elevated high sensitivity C-reactive protein (hsCRP), an acute phase reactant that belongs to the short pentraxin arm of the pentraxin superfamily, has been associated with CKD and CVD and has been suggested to provide prognostic information in CKD patients [2]. This evidence concerns the gene CRP and chronic kidney disease.